GlassScriptPhysician profile
Christopher Simon Reese
NPI 1205876976
$6,906.35
in general payments reported to CMS, 2019-2025
43 companies · $2,313 in 2025
The $2,313 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $627 · 2021: $627 · 2022: $847 · 2023: $975 · 2024: $900 · 2025: $2,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,098 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,098.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,170.63 | 2019-2025 | Xtandi, Myrbetriq |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Janssen Biotech, INC. | $698.34 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $604.50 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $565.53 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $308.22 | 2021-2025 | Posluma |
| Antares Pharma, INC. | $291.89 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Conmed Corporation | $176.34 | 2022 | |
| Abbvie INC. | $165.25 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $159.65 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $154.14 | 2020-2024 | |
| Bioprotect Medical, INC. | $138.32 | 2024 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $131.03 | 2020 | |
| Urogen Pharma, INC. | $124.26 | 2020-2025 | |
| Genzyme Corporation | $121.78 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.